Orchestra BioMed (OBIO) Tops Q2 EPS by 1c

August 10, 2026 6:19 PM EDT

Orchestra BioMed (NASDAQ: OBIO) reported Q2 EPS of ($0.38), $0.01 better than the analyst estimate of ($0.39).

For earnings history and earnings-related data on Orchestra BioMed (OBIO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK